JP2013536836A5 - - Google Patents

Download PDF

Info

Publication number
JP2013536836A5
JP2013536836A5 JP2013527016A JP2013527016A JP2013536836A5 JP 2013536836 A5 JP2013536836 A5 JP 2013536836A5 JP 2013527016 A JP2013527016 A JP 2013527016A JP 2013527016 A JP2013527016 A JP 2013527016A JP 2013536836 A5 JP2013536836 A5 JP 2013536836A5
Authority
JP
Japan
Prior art keywords
pyrimidin
pyrazolo
methanol
pyrrolidin
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013527016A
Other languages
English (en)
Japanese (ja)
Other versions
JP5859544B2 (ja
JP2013536836A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2011/006474 external-priority patent/WO2012030170A2/ko
Publication of JP2013536836A publication Critical patent/JP2013536836A/ja
Publication of JP2013536836A5 publication Critical patent/JP2013536836A5/ja
Application granted granted Critical
Publication of JP5859544B2 publication Critical patent/JP5859544B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013527016A 2010-08-31 2011-08-31 カンナビノイド1受容体阻害剤としての新規化合物 Expired - Fee Related JP5859544B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20100085042 2010-08-31
KR10-2010-0085042 2010-08-31
PCT/KR2011/006474 WO2012030170A2 (ko) 2010-08-31 2011-08-31 카나비노이드 1 수용체 저해제로 작용하는 신규 화합물

Publications (3)

Publication Number Publication Date
JP2013536836A JP2013536836A (ja) 2013-09-26
JP2013536836A5 true JP2013536836A5 (https=) 2014-10-16
JP5859544B2 JP5859544B2 (ja) 2016-02-10

Family

ID=45773400

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013527016A Expired - Fee Related JP5859544B2 (ja) 2010-08-31 2011-08-31 カンナビノイド1受容体阻害剤としての新規化合物

Country Status (6)

Country Link
US (1) US8975264B2 (https=)
EP (1) EP2617723A4 (https=)
JP (1) JP5859544B2 (https=)
KR (1) KR101914161B1 (https=)
CN (1) CN103153999B (https=)
WO (1) WO2012030170A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020531519A (ja) 2017-08-21 2020-11-05 ナビゲン,インコーポレーテッド Arf6阻害剤及び関連する方法
CN109856394B (zh) * 2019-04-16 2022-04-19 浙江诺迦生物科技有限公司 一种基于细胞多巴胺释放效应的大麻素类活性物质的检测方法及其检测试剂盒
WO2020232350A1 (en) * 2019-05-15 2020-11-19 The Regents Of The University Of Colorado, A Body Corporate Assays for synthetic cannabinoids
CN112007156A (zh) * 2019-05-30 2020-12-01 复旦大学 大麻素受体药物在制备治疗心肌细胞坏死性凋亡药剂中的应用
CN112755189A (zh) * 2019-11-02 2021-05-07 复旦大学 1型大麻素受体拮抗剂在制备治疗心肌细胞焦亡药剂中的应用
TWI907472B (zh) * 2020-08-05 2025-12-11 匈牙利商羅特格登公司 具藥理活性之經雜環取代的吡唑并〔1,5-a〕嘧啶衍生物
KR102912267B1 (ko) * 2023-04-20 2026-01-15 한국화학연구원 신규한 헤테로고리 화합물 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 포함하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176210B2 (en) * 2003-02-10 2007-02-13 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
GB0515026D0 (en) * 2005-07-21 2005-08-31 Novartis Ag Organic compounds
TW201345908A (zh) * 2006-07-05 2013-11-16 Mitsubishi Tanabe Pharma Corp 吡唑并〔1,5-a〕嘧啶化合物
AR061793A1 (es) * 2006-07-05 2008-09-24 Mitsubishi Tanabe Pharma Corp Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
CN101671336B (zh) * 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP2013536836A5 (https=)
RU2431635C2 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
Baumann et al. An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals
EP2694509B1 (en) Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of tropomyosin-related kinases
CA2800541C (en) Soluble guanylate cyclase activators
ES2287263T3 (es) Inhibidores de cinasas dependientes de ciclina como agentes anticancerigenos.
JP2019070032A5 (https=)
JP2016510035A5 (https=)
NZ525334A (en) Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
CA2545527A1 (en) Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
CA2502511A1 (en) Cannabinoid receptor ligands and uses thereof
JP2012519693A5 (https=)
IL314404A (en) Pyrrolopyrimidines as CFTR enhancers
JP2009511504A5 (https=)
JP5859544B2 (ja) カンナビノイド1受容体阻害剤としての新規化合物
JP2014511869A5 (https=)
JP2006522799A5 (https=)
MX2011009822A (es) Derivados de tienopirimidinadiona como moduladores del trpa1.
RU2004130440A (ru) Производные 4-(имидазол-5-ил)-2-(4-сульфоанилино)пиримидина, обладающие ингибирующим действием по отношению к cdk
CN101454327A (zh) 作为大麻素1活性抑制剂的吡咯并嘧啶类化合物
CN104080787A (zh) 吡唑并吡咯烷化合物
RU2013105450A (ru) Новые производные гомопиперзина в качестве ингибиторов протеинтирозинкиназ и их фармацевтическое применение
JP2010502576A5 (https=)
Song et al. Microwave-assisted synthesis of some novel fluorinated pyrazolo [3, 4-d] pyrimidine derivatives containing 1, 3, 4-thiadiazole as potential antitumor agents
RU2015132105A (ru) Азоловые производные бензола